Ryoko Wada
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Therapeutic Potential of αS Evolvability for Neuropathic Gaucher Disease.
Journal: Biomolecules
Published: January 14, 2021
Diabetes, inflammation, and the adiponectin paradox: Therapeutic targets in SARS-CoV-2.
Journal: Drug discovery today
Published: November 16, 2020
Adiponectin paradox as a therapeutic target of the cancer evolvability in aging.
Journal: Neoplasia (New York, N.Y.)
Published: September 16, 2020
Adiponectin Paradox as a Therapeutic Target in Alzheimer's Disease.
Journal: Journal of Alzheimer's disease : JAD
Published: July 06, 2020
Connecting Alzheimer's Disease With Diabetes Mellitus Through Amyloidogenic Evolvability.
Journal: Frontiers in aging neuroscience
Published: June 25, 2020
Understanding Creutzfeldt-Jackob disease from a viewpoint of amyloidogenic evolvability.
Journal: Prion
Published: May 08, 2020
Possible Role of Amyloidogenic Evolvability in Dementia with Lewy Bodies: Insights from Transgenic Mice Expressing P123H β-Synuclein.
Journal: International journal of molecular sciences
Published: January 19, 2020
Possible Role of Amyloid Cross-Seeding in Evolvability and Neurodegenerative Disease.
Journal: Journal of Parkinson's disease
Published: September 17, 2019
Current and future clinical utilities of Parkinson's disease and dementia biomarkers: can they help us conquer the disease?
Journal: Expert review of neurotherapeutics
Published: July 31, 2019
Adiponectin Paradox in Alzheimer's Disease; Relevance to Amyloidogenic Evolvability?
Journal: Frontiers in endocrinology
Published: July 04, 2019
Transgenerational Interaction of Alzheimer's Disease with Schizophrenia through Amyloid Evolvability.
Journal: Journal of Alzheimer's disease : JAD
Published: February 12, 2019
Last Updated: 09/26/2026